Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Methylnaltrexone (MNTX) for the Relief of Constipation

This study has been completed.
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Valeant Pharmaceuticals International, Inc.
ClinicalTrials.gov Identifier:
NCT00402038
First received: November 17, 2006
Last updated: July 18, 2011
Last verified: July 2011